In addition, LMO1 expression levels are also higher in human neuroblastoma cell lines of the adrenergic subtype and lower in the mesenchymal type (Figure 4C and Supplemental Table 2), consistent with our recent study showing that LMO1 is an essential transcriptional cofactor of the adrenergic CRC (13). The gene discussed is LMO1; the disease is neuroblastoma.